Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)
Latest Information Update: 06 Oct 2015
Price :
$35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin; Bivalirudin
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Biomarker; Pharmacodynamics
- Acronyms RAPID2
- 06 Oct 2015 Status is changed from recruiting to completed as per CT.gov
- 18 Mar 2013 New trial record